GSK Egypt’s consolidated profits soar 376% YoY in 2022

Reuters Images

Standalone net profits after tax surged 332.4% to EGP 718.18 million in 2022 from EGP 166.11 million in 2021

Staff Writer, Arab Finance

April 5, 2023

PHOTO

GlaxoSmithKline Egypt’s (GSK) consolidated net profits after tax and non-controlling interest soared 375.6% year on year (YoY) to EGP 735.38 million in 2022, compared to EGP 154.64 million, the firm’s income statement showed on April 4th.

Net revenues registered EGP 1.82 billion last year, up from EGP 1.01 billion in the year before.

Standalone net profits after tax surged 332.4% to EGP 718.18 million in 2022 from EGP 166.11 million in 2021.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.